The Future of MASH Management: New Drugs and Their Impact
The Future of MASH Management: New Drugs and Their Impact REZDIFFRA’s Approval: A Game Changer in MASH Treatment The approval of Rezdiffra marks a significant turning point in the treatment of metabolic-associated steatohepatitis (MASH), revolutionizing the therapeutic landscape. Unlike conventional approaches that relied heavily on lifestyle m